Clinical trials myasthenia gravis
WebDec 11, 2024 · The purpose of this study is to evaluate the safety, tolerability, and efficacy of M281 administered to participants with generalized myasthenia gravis (gMG) who have an insufficient clinical response to ongoing standard of care therapy. WebApr 13, 2024 · Clinical Trial Data for Efgartigimod in the Treatment of Myasthenia Gravis Apr 13, 2024 A. Gordon Smith, MD, FAAN A. Gordon Smith, MD, FAAN, discusses the findings and implications of phase 3 ADAPT trial and open-label extension study evaluating the use of efgartigimod in the treatment of patients with myasthenia gravis. EP: 1.
Clinical trials myasthenia gravis
Did you know?
Web1 day ago · The RAISE trial was led by James Howard, MD, professor of neurology at the UNC School of Medicine. Generalized myasthenia gravis is a rare, chronic, and … WebJul 11, 2024 · MG severity Class I to IVa on the MGFA (Myasthenia Gravis Foundation of America) Clinical Classification; Exclusion Criteria: Rituximab in the last 12 months. Prednisone > 0.25mg/kg/day [in Part A] Other autoimmune disorder requiring immunosuppressive therapies. Investigational treatment for MG in the past 12 weeks.
WebJul 29, 2024 · Diagnosis of myasthenia gravis. Positive serologic test for anti-acetylcholine receptor antibodies. Myasthenia Gravis Foundation of America Clinical Classification Class II to IV at Screening. MG-ADL profile must be ≥ 5. Participants receiving stable treatment with azathioprine; other immunosuppressive therapies. WebA Phase II Trial of Rituximab in Myasthenia Gravis. NCT02110706. ... 18-69] years), clinical improvement was observed in parallel with complete withdrawal or reduction of other immunotherapies, with all patients achieving complete stable remission, pharmacologic remission, or minimal manifestations based on the Myasthenia Gravis …
WebMyasthenia gravis is a rare, chronic autoimmune disease of the neuromuscular junction that is characterised by muscle weakness. Most people with the disease have antibodies against one of the transmembrane proteins at the synapse, such as the acetylcholine receptor (AChR) or muscle-specific tyrosine kinase (MuSK). WebApr 15, 2024 · A male participant must take effective contraception during this clinical trial or their heterosexual partner must take effective contraception. Meets MGFA myasthenia gravis clinical classification IIa-IVa (includes types IIa, IIb, IIIa, IIIb, and IVa) at the screening visit and at the baseline visit.
WebDec 10, 2024 · A Long-Term, Single-Arm, Open-Label, Multicenter, Phase 3 Follow-on Trial of ARGX-113-1704 to Evaluate the Safety and Tolerability of ARGX-113 in Patients With Myasthenia Gravis Having Generalized Muscle Weakness: Actual Study Start Date : March 1, 2024: Actual Primary Completion Date : June 23, 2024: Actual Study Completion Date …
WebClinical Trials. Currently, more than 50 trials for myasthenia gravis (MG) are active or recruiting. The interventions being evaluated range from surgical procedures to … progressive professional food chopperWebMar 21, 2024 · Thymic hyperplasia was found in 20.2% of the patients. Younger patients were more likely to relapse. The rate of adult early-onset myasthenia gravis reaching … progressive products llc disinfecting wipesWebApr 13, 2024 · The MycarinG study (NCT03971422) is a multi-center, Phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of … kzn learnership 2022WebApr 7, 2024 · Results. We identified 84 patients with MG, 11 of whom (13%) met criteria for refractory MG. Mean (standard deviation) age was 47 (18) years; 64% of patients with … progressive profiling unbounceWebIn The Lancet Neurology, two randomised placebo-controlled trials are reported of new therapies for autoimmune myasthenia gravis that target these pathogenic mechanisms. … kzn looting latest newsWebJan 9, 2024 · On October 27, 2024, Conquer Myasthenia Gravis hosted its Fall Patient Seminar. Speakers: Rabia Malik, MD, Asst. Professor, Rush University Medical Center. … progressive profiling autopilothqWebTo achieve this goal, we are committed to creating awareness about clinical trials for those with myasthenia gravis and related neuromuscular joint disorders. If you would like your clinical trial posted to our website, please complete the Research Announcement Form … kzn library services